Hypofractionated Radiotherapy and Concurrent Cisplatin for Head and Neck Cancer

NCT03194061 ↗

Unknown 20 enrolled Barretos Cancer Hospital

NaSingle-groupOpen-labelTreatment

Summary

The aim of this study is to evaluate the feasibility of hypofractionated radiation therapy and concomitant chemotherapy with cisplatin for locally advanced head and neck cancer in a high volume brazilian center.

Timeline

Start: 2015-01-01
Primary completion: 2019-08-31
Completion: 2019-08-31

Publications

Jacinto AA, Batalha Filho ES, Viana LS, De Marchi P, Capuzzo RC, Gama RR, Boldrini Junior D, Santos CR, Pinto GDJ, Dias JM, Canton HP, Carvalho R, Radicchi LA, Bentzen S, Zubizarreta E, Carvalho AL. Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma. BMC Cancer. 2018 Oct 23;18(1):1026. doi: 10.1186/s12885-018-4893-5.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cisplatin	Other / unclassified	35 mg/m2	—

Indications

No indication recorded.